YAP1 and chronic obstructive pulmonary disease: On the other hand, aberrant YAP/TAZ signaling participates in the pathophysiology of chronic respiratory diseases, such as lung malignancies, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), asthma, lung infections, and PF [34].